Barclays analyst Matt Miksic raised the firm’s price target on Medtronic (MDT) to $109 from $105 and keeps an Overweight rating on the shares. The firm continues to expect accelerating earnings ...
Wells Fargo analyst Larry Biegelsen lowered the firm’s price target on Medtronic (MDT) to $98 from $106 and keeps an Overweight rating on the shares after the company reported a Q2 revenue beat.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback